Case File
efta-02570300DOJ Data Set 11OtherEFTA02570300
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02570300
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Thomas Turrin <
Sent:
Tuesday, May 21, 2013 12:39 PM
To:
Jeffrey Epstein
Subject:
RE: Re:
<=p>
From: Jeffrey =pstein (mailto:jeevacation@gmaitcomj
Sent: Tuesday, May 21, 2013 8:34 AM
To: Thomas Turrin
Subject: Re:
On Tuesday, May 21, 2013, Thomas Turrin wrote:
Jeffrey,
1
EFTA_R1_01738183
EFTA02570300
Best,
Torn
THOMAS TURRIN, CPA
Partner
Raich Ende Malter & Co. LLP
1375 Broadwayap>
New York, New York 10018a:p>
Email:
<javascript:_e(%7b%7d,%201cvmr,%[email protected]);>
Website: www.rem-co.com <http://www.rem-co.com>
2
EFTA_R1_01738184
EFTA02570301
From: Jeffrey Epstein (mailt=:[email protected] <javascript:_e(%7b%7d,%20'cvmr,%[email protected];>
Sent: Monday, May 20, 2013 5:03 PM
To: Thomas Turrin
Subject: Re:
On Mon, May 20, 2013 at 4:35 PM, Thomas Turrin <
THOMAS TURRIN, CPA
Partner
Raich Ende Malter & Co. LLP
1375 Broadway
New York, New York 10018</=:p>
Email:
<mailto
Website: www.rem-co.com <http://www.rem-co.com>
<mailto
> wrote:
3
EFTA_R1_01738185
EFTA02570302
From: Jeffrey Epstein (mailto:[email protected])
Sent: Monday, May 20, 2013 2:40 PM
To: Thomas Turrin
Subject:
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
&n=sp;
&n=sp;
CONFIDENTIALITY STATEMENT: The information contained in this elect=onic communication, including any and all
attachments and enclosures, may be privileged and is strictly confidential, intended s=lely for the use of the person(s)
identified above to receive this communi=ation. If you are not the person(s) identified above to receive this
commu=ication, you are hereby notified that you may not disclose print, copy, disseminate, or otherwise use the
i=formation contained herein. If you are an employee or agent of the person(=) identified above to receive this
communication and, as such, you have be=n authorized to deliver this communication to such person(s), you may
disclose, print, copy, disseminate, or otherwis= use the information contained in this communication solely for the
purpos= of such delivery. Unauthorized interception and/or use of this communicat=on are/is strictly prohibited and
may be punishable by law. If you have received this communication in error= please reply and notify the sender (only) of
that fact and delete the com=unication, including any and all attachments and enclosures, from your com=uter or other
electronic device on which you may have received this communication.
4
EFTA_R1_01738186
EFTA02570303
CIRCULAR 230 DISCLOSURE: To insure compliance with requirements imposed by the Internal Reven=e Service, we
inform you that any tax advice contained in this communication (including any and all attachments), unles= expressly
stated otherwise, was not intended or written to be used and ca=not be used for the purpose of (i) avoiding tax-related
penalties imposed =y the Internal Revenue Code or (ii) promoting, marketing, or recommending to another party any
transactio=(s) or tax-related matter(s) addressed herein. This communication may not =e forwarded (other than to the
addressee(s) identified above) without our =xpress written consent.
5
EFTA_R1_01738187
EFTA02570304
Technical Artifacts (8)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Phone
2570300Phone
2570301Phone
2570302Phone
2570303Phone
2570304URL
http://www.rem-co.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.